HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$16.67
Day range
$16.53 - $19.55
Year range
$7.64 - $20.62
Market cap
813.51M USD
Avg Volume
583.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 45.48M | 31.43% |
Net income | -23.80M | 11.12% |
Net profit margin | — | — |
Earnings per share | -0.54 | 8.47% |
EBITDA | -45.41M | -31.43% |
Effective tax rate | 35.59% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 467.07M | -0.05% |
Total assets | 484.18M | -13.71% |
Total liabilities | 30.29M | 16.10% |
Total equity | 453.90M | — |
Shares outstanding | 43.07M | — |
Price to book | 1.58 | — |
Return on assets | -23.23% | — |
Return on capital | -24.40% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -23.80M | 11.12% |
Cash from operations | -18.13M | 27.43% |
Cash from investing | 51.47M | 279.90% |
Cash from financing | 248.00K | 100.75% |
Net change in cash | 33.59M | 138.83% |
Free cash flow | -16.95M | 21.22% |
About
Founded
2016
Website
Employees
85